The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical chemistry and laboratory medicine 2021-10, Vol.59 (11), p.405-408
Hauptverfasser:	Pascreau, Tiffany, Ballester, Marie-Christine, Van Dreden, Patrick, Zia-Chahabi, Sara, Zuber, Benjamin, Choucair, Jad, Bironien, Roselyne, Farfour, Eric, Vasse, Marc
Format:	Artikel
Sprache:	eng
Schlagworte:	anti-PF4/heparin antibodies Antibodies Anticoagulants Biology Coronaviruses COVID-19 Extracorporeal membrane oxygenation Hematology Heparin heparin induced thrombocytopenia Hospitalization Hospitals Human health and pathology Life Sciences Thrombocytopenia Thromboembolism Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!